Cassava’s Shares Plunge as Alzheimer’s Drug Fails Phase III
After promising to set the record straight on the potential of simufilam to help with Alzheimer’s disease, Cassava Sciences reported...
After promising to set the record straight on the potential of simufilam to help with Alzheimer’s disease, Cassava Sciences reported...
News ReleaseTuesday, October 15, 2024 NIH-funded brain mapping study uncovers which cell types may be harmed first. Alzheimer’s disease may...
Aging and Alzheimer's leave the brain starved of energy. Now scientists think they've found a way to aid the brain's...